共 108 条
[1]
Lee MS(2010)Does moxibustion work? An overview of systematic reviews BMC Res Notes. 3 54-63
[2]
Kang JW(2013)Extending the CONSORT Statement to moxibustion J Integr Med. 11 726-732
[3]
Ernst E(2010)Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med. 152 261-275
[4]
Cheng CW(2017)Quality assessment of randomized controlled trials of moxibustion using STandards for Reporting Interventions in Clinical Trials of Moxibustion (STRICTOM) and risk of bias (ROB) J Acupunct Meridian Stud. 10 1-50
[5]
Fu SF(2009)The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement PLoS Med. 6 352-35
[6]
Zhou QH(2015)Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement Syst Rev. 4 43-632
[7]
Wu TX(2016)PRISMA harms checklist: improving harms reporting in systematic reviews BMJ. i157 1-132
[8]
Shang HC(2017)AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement & checklist J Clin Epidemiol. 90 625-103
[9]
Tang XD(2019)Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist BMC Complement Altern Med. 19 128-775
[10]
Schulz KF(2020)PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) extension for Chinese herbal medicines 2020 (PRISMA-CHM 2020) Am J Chin Med. 48 348-367